Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Translational Cancer Research|September 4, 2018
ONC201: a new treatment option being tested clinically for recurrent glioblastomaMarie D Ralff, Amriti R Lulla, Jessica Wagner, et al.
American Journal of Cancer Research|February 10, 2022
miR-3132 upregulates surface TRAIL to induce apoptotic cell death in cancer cellsAmriti R Lulla, Yan Zhou, Marie D Ralff, et al.
Cancer Biology & Therapy|September 9, 2017
Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancerAvital Lev, Safoora Deihimi, Elena Shagisultanova, et al.
Cancer Research|October 25, 2017
miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer CellsAmriti R Lulla, Michael J Slifker, Yan Zhou, et al.
Cancer Research|January 14, 2016
Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 ActivationVarun V Prabhu, Bo Hong, Joshua E Allen, et al.
Molecular Cancer Research : MCR|March 29, 2018
ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate CancerAvital Lev, Amriti R Lulla, Brian C Ross, et al.
Neoplasia (New York, N.Y.)|December 8, 2017
Role of Dopamine Receptors in the Anticancer Activity of ONC201Christina Leah B Kline, Marie D Ralff, Amriti R Lulla, et al.
Molecular Cancer Therapeutics|October 5, 2023
Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung MetastasisAmriti R Lulla, Said Akli, Cansu Karakas, et al.
Oncotarget|November 16, 2017
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIPAvital Lev, Amriti R Lulla, Jessica Wagner, et al.
Oncogenesis|May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancersAmriti R Lulla, Said Akli, Cansu Karakas, et al.
Pageof 2